Health Condition 1: K135- Oral submucous fibrosis
Conditions
Interventions
None listed
Sponsors
Dr Komal Deotale
Eligibility
Inclusion criteria
Inclusion criteria: Patients with stage 2 OSMF with i.e mouth opening between 25mm-35mm according to Chandramani More Classification
Exclusion criteria
Exclusion criteria: 1. Patients with other intra oral lesions. 2. Patients with known hypersensitivity to triphala. 3. Patients with prior treatment for OSMF.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Triphala is efficacious in management of Oral Submucous Fibrosis in terms of increase in mouth opening, reduction in burning sensation and increase in tongue protrusion which will be measured and recorded at baseline, 1st, 2nd and 3rd month. Timepoint: Pre-operative Burning Sensation, Interincisal Mouth Opening and Tongue Protrusion will be measured. These clinical parameters will be measured and recorded at baseline, 1st , 2nd , and 3rd month. | — |
Secondary
| Measure | Time frame |
|---|---|
| Triphala is as efficacious as lycopene in management of Oral Submucous Fibrosis in terms of increase in mouth opening, increase in tongue protrusion and reduction in burning sensation.Timepoint: All the parameters will be recorded at baseline, at every 15th day and after 3 months | — |
Countries
India
Contacts
Public ContactDr Ashish lanjekar
Swargiya Dadasaheb Kalmegh Smruti Dental College And Hospital
Outcome results
None listed